AUSTIN, Texas, May 04, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing novel, targeted therapies for rare and ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The clinical development plan is a blueprint that brings a new drug discovery from preclinical development to market approval. It helps to regulate the process of drug discovery, ensuring patient ...

Chugai Pharmaceutical Co., Ltd., SoftBank Corp., and its subsidiary SB Intuitions Corp. announced today that they have signed a Memorandum of Understanding, effective January 30, 2025, to conduct ...

Louvain-la-Neuve, Belgium — June 17th, 2025 : One2Treat SA, a fast-growing tech company incorporating the patient voice in all strategic decisions about treatment assessments in Pharma R&D, today ...

Syneos Health SYNH recently announced a strategic collaboration that will expand its relationship with Oracle. The partnership will utilize the Oracle Cerner Learning Health Network (“LHN”) and the ...

Simultaneous China and global clinical development strategy to expedite development process - HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ...

RESEARCH TRIANGLE PARK, N.C., July 14, 2025--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics ...

Topline data from the chronic cohort is expected in Q2 2025 Institutional Review Board (IRB) protocol amendment changes approved, and screening has been initiated for subacute cohort This news release ...